Top 20 of Kidney Failure, Chronic

Article title # Publications/# Citations

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

1999: JPBosch; TGreene; ASLevey; JBLewis; NRogers; DRoth;

1584

Vitamin D deficiency.

2007: MFHolick;

1130

Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

2010: American Heart Association Statistics Committee and Stroke Statistics Subcommittee; RJAdams; JDBerry; TMBrown; MRCarnethon; SDai; Gde Simone; ESFord; ... CSFox; HJFullerton; CGillespie; ASGo; KJGreenlund; SMHailpern; JAHeit; PMHo; VJHoward; BMKissela; SJKittner; DTLackland; JHLichtman; LDLisabeth; DMLloyd-Jones; DMMakuc; GMMarcus; AMarelli; DBMatchar; MMMcDermott; JBMeigs; CSMoy; DMozaffarian; MEMussolino; GNichol; NPPaynter; VLRoger; WDRosamond; PDSorlie; RSStafford; TNTuran; MBTurner; NDWong; JWylie-Rosett;

807

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

2001: RENAAL Study Investigators; BMBrenner; MECooper; Dde Zeeuw; WFKeane; WEMitch; HHParving; GRemuzzi; ... SShahinfar; SMSnapinn; ZZhang;

481

The Health Belief Model: a decade later.

1984: MHBecker; NKJanz;

409

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

2001: Collaborative Study Group; RCAtkins; TBerl; WRClarke; LGHunsicker; EJLewis; JBLewis; MAPohl; ... IRaz; ERitz; RRohde;

349

Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence.

2000: TWCroghan; MRDiMatteo; HSLepper;

294

Assessing kidney function--measured and estimated glomerular filtration rate.

2006: JCoresh; TGreene; ASLevey; LAStevens;

289

Clinical epidemiology of cardiovascular disease in chronic renal disease.

1998: RNFoley; PSParfrey; MJSarnak;

245

Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

2010: AJBernhardy; DWBowden; BIFreedman; DJFriedman; GGenovese; PJHicks; JBKopp; CDLangefeld; ... LLecordier; GWNelson; TKOleksyk; EPays; MRPollak; MDRoss; ALUscinski Knob; PUzureau; BVanhollebeke; CAWinkler;

239

Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.

1999: LYAgodoa; VBAshby; REEttenger; PJHeld; ELMilford; AOOjo; FKPort; RAWolfe;

233

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.

2008: OMGutiérrez; TIsakova; HJüppner; HLee; MMannstadt; JARauh-Hain; AShah; KSmith; ... HTamez; RThadhani; MWolf;

228

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

2004: GABlock; GMChertow; PSKlassen; JMLazarus; EGLowrie; NOfsthun;

215

MYH9 is associated with nondiabetic end-stage renal disease in African Americans.

2008: Family Investigation of Nephropathy and Diabetes Research Group; HEAbboud; SGAdler; YBerthier-Schaad; JCoresh; JDivers; NEFink; BIFreedman; ... SKIyengar; WHKao; PLKimmel; MJKlag; WCKnowler; OFKohn; KKramp; DJLeehey; MLi; LAMeoni; SBNicholas; MVPahl; RSParekh; NPatterson; NRPowe; DReich; JHSadler; JRSchelling; JRSedor; MWSmith; ATandon; DThornley-Brown; MRWeir; CAWinkler;

204

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.

2000: JChung; RMElashoff; AEmerick; BGales; JGoldin; WGGoodman; LGreaser; BDKuizon; ... IBSalusky; DSider; YWang; CYoon;

190

Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis.

2000: PGAllen; AHBeggs; LACorreia; JMKaplan; SHKim; BJMathis; KNNorth; MRPollak; ... HRennke; JCRodríguez-Pérez; HQTong;

190

Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases.

2003: VEremina; NFerrara; HPGerber; JHaigh; YKikkawa; GLajoie; JHMiner; ANagy; SEQuaggin; MSood;

184

HLA-mismatched renal transplantation without maintenance immunosuppression.

2008: RBColvin; ABCosimi; BDey; RDing; JAFishman; NBGoes; MHertl; TKawai; ... DSKo; FIPreffer; DHSachs; SLSaidman; JShaffer; VSharma; TRSpitzer; MSuthanthiran; MSykes; NTolkoff-Rubin; WWWilliams; WWong;

181

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

2002: African American Study of Kidney Disease and Hypertension Study Group; LYAgodoa; LJAppel; GBakris; JCharleston; DCheek; JGDouglas-Baltimore; JGassman; ... RGlassock; TGreene; LHebert; KJamerson; JLewis; JPMiddleton; RAPhillips; SGRostand; RDToto; JTWright;

179

Ethnic disparities in diabetic complications in an insured population.

2002: LMAckerson; AFerrara; AJKarter; JYLiu; HHMoffet; JVSelby;

177